PanGen Biotech Inc (222110) — Cash Flow Quality Index
PanGen Biotech Inc (222110) has a Cash Flow Quality Index of -6.88x as of September 2025. Operating cash flow of ₩-3.66 Billion is below net income of ₩531.94 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PanGen Biotech Inc (222110) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PanGen Biotech Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for PanGen Biotech Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check PanGen Biotech Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for PanGen Biotech Inc (2024–2024)
Year-by-year earnings quality comparison for PanGen Biotech Inc. For live market cap and the full company financial profile, see PanGen Biotech Inc market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.17x | ₩2.99 Billion | ₩943.69 Million | — |